Have you read these stories?

Why India needs a composite strategy to combat Coronavirus

There might seem to be many options, but effectively there is only one. That is what India is looking at right now.

credit facility

01 April, 2020, 07:05 AM IST



Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility

Shares of Aurobindo Pharma were trading at Rs 508.50 a piece on BSE.

USFDA issues warning letter to Cipla for Goa manufacturing facility

Drug firm Cipla Ltd said that the US health regulator has issued a warnin...

Rs 37 lakh penalty on Samsung for not passing GST credit

The NAA further said in its order that Samsung India had increased prices for approp...

Load More...

Other useful Links

Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service